Search Results - "Roselt, Peter D"
-
1
Effective Preparation of [ 18 F]Flumazenil Using Copper-Mediated Late-Stage Radiofluorination of a Stannyl Precursor
Published in Molecules (Basel, Switzerland) (13-09-2022)“…(1) Background: [18F]Flumazenil 1 ([18F]FMZ) is an established positron emission tomography (PET) radiotracer for the imaging of the gamma-aminobutyric acid…”
Get full text
Journal Article -
2
Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE
Published in EJNMMI radiopharmacy and chemistry (08-05-2024)“…Background Automated [ 89 Zr]Zr-radiolabeling processes have the potential to streamline the production of [ 89 Zr]Zr-labelled PET imaging agents. Most…”
Get full text
Journal Article -
3
Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform
Published in EJNMMI radiopharmacy and chemistry (23-08-2019)“…Background Gallium-68 ([ 68 Ga]Ga) labelled radiopharmaceuticals have become a valuable tool in clinical practice using Positron Emission Tomography (PET)…”
Get full text
Journal Article -
4
One-step radiosynthesis of 4-nitrophenyl 2-[18F]fluoropropionate ([18F]NFP); improved preparation of radiolabeled peptides for PET imaging
Published in Journal of labelled compounds & radiopharmaceuticals (01-12-2013)“…The versatile 18F‐labeled prosthetic group, 4‐nitrophenyl 2‐[18F]fluoropropionate ([18F]NFP), was synthesized in a single step in 45 min from 4‐nitrophenyl…”
Get full text
Journal Article -
5
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention
Published in Angewandte Chemie International Edition (14-10-2019)“…Molecules containing lysine‐ureido‐glutamate functional groups bind to the active site of prostate specific membrane antigen, which is overexpressed in…”
Get full text
Journal Article -
6
Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin‑2 Receptor Positive Cancers
Published in Journal of medicinal chemistry (10-08-2023)“…Peptide receptor radionuclide therapy (PRRT) is a promising form of systemic radiation therapy designed to eradicate cancer. Cholecystokinin-2 receptor (CCK2R)…”
Get full text
Journal Article -
7
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer
Published in Journal of medicinal chemistry (10-09-2020)“…Prostate-specific membrane antigen (PSMA) is a carboxypeptidase that is overexpressed in prostate cancer and is an excellent candidate for targeted diagnostic…”
Get full text
Journal Article -
8
A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin‑2 Receptor-Positive Cancer
Published in Journal of medicinal chemistry (22-04-2021)“…Proteins adopt unique folded secondary and tertiary structures that are responsible for their remarkable biological properties. This structural complexity is…”
Get full text
Journal Article -
9
Copper Bis(thiosemicarbazonato)-stilbenyl Complexes That Bind to Amyloid‑β Plaques
Published in Inorganic chemistry (17-08-2020)“…Alzheimer’s disease is characterized by the presence of extracellular amyloid-β plaques. Positron emission tomography (PET) imaging with tracers radiolabeled…”
Get full text
Journal Article -
10
Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups
Published in Inorganic chemistry (01-04-2019)“…The synthesis of new bis(thiosemicarbazonato)copper(II) complexes featuring polyamine substituents via selective transamination reactions is presented…”
Get full text
Journal Article -
11
Precision peptide theranostics: developing N - to C -terminus optimized theranostics targeting cholecystokinin-2 receptor
Published in Theranostics (01-01-2024)“…Peptides are ideal for theranostic development as they afford rapid target accumulation, fast clearance from background tissue, and exhibit good tissue…”
Get full text
Journal Article -
12
Imaging Somatostatin Positive Tumors with Tyr3‑Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68
Published in Bioconjugate chemistry (21-07-2021)“…Radiolabeled derivatives of Tyr3-octreotide and Tyr3-octreotate, synthetic analogues of the peptide hormone somatostatin, can be used for positron emission…”
Get full text
Journal Article -
13
Gallium Fluoride Complexes with Acyclic Bispicolinic Ligands as Potential New Fluorine‐18 Labelled Imaging Agents
Published in European journal of inorganic chemistry (22-09-2020)“…The positron‐emitting radionuclide, fluorine‐18, is used to radiolabel molecules to develop tracers for diagnostic imaging with positron‐emission tomography…”
Get full text
Journal Article -
14
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu
Published in The Journal of nuclear medicine (1978) (01-06-2021)“…Radionuclide therapy targeting prostate-specific membrane antigen (PSMA) is promising for prostate cancer. We previously reported a ligand, 64Cu-CuSarbisPSMA,…”
Get full text
Journal Article -
15
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67 Cu
Published in Journal of Nuclear Medicine (01-06-2021)“…Radionuclide therapy targeting prostate-specific membrane antigen (PSMA) is promising for prostate cancer. We previously reported a ligand, Cu-CuSarbisPSMA,…”
Get full text
Journal Article -
16
Imaging Somatostatin Positive Tumors with Tyr 3 -Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68
Published in Bioconjugate chemistry (21-07-2021)“…Radiolabeled derivatives of Tyr -octreotide and Tyr -octreotate, synthetic analogues of the peptide hormone somatostatin, can be used for positron emission…”
Get full text
Journal Article -
17
4-Nitrophenyl activated esters are superior synthons for indirect radiofluorination of biomolecules
Published in RSC medicinal chemistry (01-08-2020)“…Indirect radiolabelling has for a long time been the mainstay strategy for radiofluorination of biomolecules. Acylation of biomolecules through the use of an…”
Get full text
Journal Article -
18
Peptide Receptor Radionuclide Therapy with 67 Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model
Published in Journal of Nuclear Medicine (01-12-2020)“…Peptide receptor radionuclide therapy (PRRT) using radiolabeled octreotate is an effective treatment for somatostatin receptor 2-expressing neuroendocrine…”
Get full text
Journal Article -
19
A Copper Complex of a Thiosemicarbazone-Pyridylhydrazone Ligand Containing a Vinylpyridine Functional Group as a Potential Imaging Agent for Amyloid-β Plaques
Published in Critical studies in media communication (01-01-2019)“…Complexes containing positron-emitting radionuclides of copper have the potential to be of use for diagnostic imaging with positron emission tomography…”
Get full text
Journal Article -
20
Radiosynthesis and preliminary in vivo evaluation of 18F-labelled glycosylated duramycin peptides for imaging of phosphatidylethanolamine during apoptosis
Published in MedChemComm (01-11-2019)“…Duramycin derivatives incorporating an [18F]-labelled prosthetic group and one or two hydrophilic sugar amino acid moieties have been prepared as potential…”
Get full text
Journal Article